Skip to main content
. 2023 Feb 11;11(2):417. doi: 10.3390/vaccines11020417

Table 1.

Description of BNT162b modRNA vaccine candidates.

BNT162 Vaccine Candidate
(Product Code)
SARS-CoV-2 Variant a Encoded Antigen Sequence Variant b
BNT162b1 Wild type SARS-CoV-2 RBD, a secreted variant V5
BNT162b2 Wild type Full-length SARS-CoV-2 S protein bearing mutations preserving neutralization-sensitive sites V8 and V9 c
BNT162b3 Wild type SARS-CoV-2 RBD, a membrane-bound variant V5TM

a Wild type refers to the USA-WA1/2020 strain. b Sequence variant refers to the nucleotide sequence of the RNA component encoding the antigen. c Note that there were two variants of the BNT162b2 vaccine tested. The RNA component of the two sequence variants (V8 and V9) have different nucleotide sequences, but both encode the same antigen. Abbreviations: RBD = receptor binding domain; S protein = spike protein; V = variant.